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Abstract 
Each year, it is expected that over 250,000 women in the United States will be diagnosed 
with breast cancer and over 40,000 women will die from the disease1. In some cases, 
breast cancer cells metastasize and form secondary tumors in other organs, such as the 
liver, the lungs, bones, and the brain2, causing a significant decline in survival rates3. It is 
not well understood why breast cancer cells behave differently from organ to organ. The 
goal of this study is to develop an understanding of breast cancer behavior in the brain 
environment by studying breast cancer cell lines in models mimicking the breast and 
brain tissue. In this study, 2 breast cancer cell lines and one normal mammary cell line 
were studied either on the surface of or encapsulated in collagen-hyaluronic acid (HA) 
hydrogel composites. The breast cancer cell lines MDA-MB-231 and MCF7 were under 
investigation, along with MCF10a, a healthy breast epithelial cell line, as a control. 
Collagen-I/III and HA were chosen because of their respective abundance in the breast 
and brain4,5. Migration and morphology patterns were analyzed to characterize 
differences between cell lines and hydrogel compositions. Results of this study revealed 
that migration of MDA-MB-231 cells was not hindered by the addition of HA, whereas 
migration of MCF-7 cells declined significantly with the addition of HA. This study 
reveals that these hydrogel models can provide viable methods to further investigate the 
migration patterns of invasive cancer cell cultures. 
iv 
 
Acknowledgments 
I would first like to thank my advisor, Dr. Jessica O. Winter, for her unwavering support 
in my research studies during my time at The Ohio State University. She has always 
helped me strive for greater heights in both my academic and research pursuits, and it 
seems impossible for me have achieved as much as I have without her counsel. 
I would like to thank Yixiao Cui, the member of the Winter lab who provided me the 
opportunity to work within the lab. She has been a wonderful mentor in research, 
academia, and beyond. Without Yixiao’s help, there is no doubt in my mind that I would 
not have made it this far into my research.  
I would also like to thank all the members of the Winter lab that I have had the pleasure 
of talking to during my time at The Ohio State University. They have all received me 
with open arms and have provided several insights into the world of nanoparticles 
research.  
I would like to thank Amanda Slager, my research partner in my sophomore and junior 
year. Without her driving me to work on the lab project, I would have likely never gotten 
anything done those years, and I would not have accelerated my research goals without 
her inspiration. 
I would like to thank Dr. Jeffrey Chalmers for serving on my thesis committee 
v 
 
I would like to thank my parents, Dr. James Allen and Dr. Elizabeth Allen, for their 
unfaltering belief in my ability to achieve the goals I set for myself. I cannot imagine 
where I would be if it were not for their help. 
Lastly, I would like to thank my close friends, Henry Schuler, Jacob Mason, Evan Meder, 
Matt Plank, Ian Lennon, Finn Haughn, Zach Sterling, and Derek Nguyen. They have 
been a great source of optimism for my goals and have helped me keep my sanity during 
my four years as an undergraduate in Chemical Engineering. 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
Vita 
Begin Typing Here 
May 2017-2020..............................................................Undergraduate Research Assistant, 
The Ohio State University 
June 2018-August 2018.......................................Undergraduate Research Apprenticeship, 
The Ohio State University 
May 2020.......................................................................B.S. Chemical Engineering, 
The Ohio State University 
 
 
 
 
 
 
 
 
 
Fields of Study 
 
Major Field: Chemical and Biomolecular Engineering 
 
vii 
 
 
Table of Contents 
 
Abstract .............................................................................................................................. iii 
Acknowledgments.............................................................................................................. iv 
Vita ..................................................................................................................................... vi 
List of Tables ...................................................................................................................... x 
List of Figures .................................................................................................................... xi 
Chapter 1. Introduction ....................................................................................................... 1 
Background ..................................................................................................................... 1 
Hydrogels ........................................................................................................................ 4 
Hyaluronic acid ............................................................................................................... 6 
Cell lines ......................................................................................................................... 7 
MDA-MB-231 ............................................................................................................ 8 
MCF7 .......................................................................................................................... 9 
MCF10a .................................................................................................................... 10 
Cell behavior: Migration and morphology ................................................................... 11 
Mesenchymal movement .......................................................................................... 12 
Amoeboid movement ................................................................................................ 13 
viii 
 
Expected results ............................................................................................................ 13 
General trends ........................................................................................................... 14 
Response to HA ........................................................................................................ 15 
Differences between 2D and 3D conditions ............................................................. 16 
Chapter 2: Methodology ................................................................................................... 18 
Cell Cultures ................................................................................................................. 18 
Model Preparation ......................................................................................................... 19 
Cell staining .............................................................................................................. 20 
Hydrogel preparation ................................................................................................ 21 
Hydrogel well preparation ........................................................................................ 23 
Microscopy ................................................................................................................... 23 
Analysis methods .......................................................................................................... 24 
Chapter 3: Results and Discussion .................................................................................... 25 
Hydrogel composition effects on migration ................................................................. 25 
Discussion on migration ............................................................................................... 28 
Overall migration differences ................................................................................... 28 
MDA-MB-231 migrational response ........................................................................ 29 
MCF7 migrational response ...................................................................................... 30 
Validity of the hydrogel models ............................................................................... 31 
ix 
 
Validity of the MCF10a cell line .............................................................................. 32 
Hydrogel composition effects on morphology ............................................................. 33 
Discussion on morphology ........................................................................................... 35 
Overall morphology response ................................................................................... 35 
MDA-MB-231 morphology response ....................................................................... 35 
MCF7 morphology response..................................................................................... 36 
Conclusions ....................................................................................................................... 37 
Bibliography ..................................................................................................................... 39 
 
 
 
 
x 
 
List of Tables 
Table 1: General time table for each conducted experiment ............................................ 20 
Table 2: Hydrogel components by percent makeup for the hydrogel base layer .............. 22 
Table 3: Hydrogel components by percent makeup for the 3D encapsulation layer ........ 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
List of Figures 
Figure 1: Characteristic behavior of cells grown on a 2D glass surface15 .......................... 5 
Figure 2: Characteristic behavior of cells grown within 3D collagen gel15 ........................ 5 
Figure 3: MDA-MB-231 cells in culture24.......................................................................... 9 
Figure 4: MCF7 cells in culture27 ..................................................................................... 10 
Figure 5: MCF10a cells in culture29.................................................................................. 11 
Figure 6: Visual representation of amoeboid (left) and mesenchymal (right) 
morphologies31 .................................................................................................................. 12 
Figure 7: Migration data from MDA-MB-231/hydrogel experiments ............................. 27 
Figure 8: Migration data from MCF-7/hydrogel experiments .......................................... 28 
Figure 9: Average aspect ratio values of MDA-MB-231 hydrogel experiments .............. 33 
Figure 10: Average aspect ratio values of MCF7 hydrogel experiments ......................... 34 
 
 
 
 
 
 
 
1 
 
Chapter 1. Introduction 
Background 
The search for treatments and therapies for those afflicted with breast cancer is an 
ongoing process. In order to develop the highest quality treatment, the means of 
migration and growth of breast cancer must be better understood. In an ideal setting, all 
cancer could be biologically characterized, resulting in an abundance of treatment 
options, thus reducing the lethality and symptomatic issues of cancer. Currently, women 
diagnosed with breast cancer in its early stages have a 100% chance of survival for 5 
years after diagnosis, whereas women diagnosed with late stage breast cancer have a 22% 
chance of survival within the same time frame2. As a result of deficiency in knowledge 
about breast cancer metastasis and post-metastatic disease, modern medicine lacks the 
ability to characterize and predict tumorigenic cell behavior in differing stages of cancer 
development. By further identifying key characteristics of breast tumorigenic cells, this 
study aims to advance the understanding of breast cancers, specifically those in stage IV. 
The progression of cancer development within the body is typically 
categorized into five stages of cancer, with the extent of cancer growth 
increasing with each step. In stage zero, no cancer has developed, only 
abnormal cells are present within a small area of the body. In stage I, 
cancer has developed within a small area in the body. In stages II and III, 
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the cancer has grown larger into a tumor and can grow into nearby tissue 
and lymph nodes. At stage IV, the cancer has travelled through the 
cardiovascular system to spread and grow within other areas of the body. 
At this point, the cancer can be considered advanced or metastatic6. For 
cancer cells to spread throughout the body, a series of migratory steps are 
required. First, the cancer cells must be capable of growing into or 
invading nearby normal tissue. Then, the cells must be capable of moving 
through the endothelial walls of nearby lymph nodes or blood vessels. 
Once this is possible, the cancer can circulate throughout the body within 
the circulatory system. The cells can then stop in small blood vessels or 
capillaries, and move through the blood vessel walls. The cancer then 
invades that nearby tissue and grows7. Once the cancer has grown into a 
tumor in this secondary position (hence why this tumor is called a 
‘secondary tumor’), the tumor then stimulates the growth of new blood 
vessels from existing vasculature to feed the expanding tumor8. 
Once the cancer is capable of metastasis, treatments are rarely 
curative. In previous years, a large center of focus was around treating the 
primary tumor in the originating area. Improving the understanding of 
metastatic cancer biology could prove key to developing better therapies 
to address metastasized cancer that might be resistant to standard 
treatments because of possible changes at the genetic and epigenetic 
level9. 
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The most frequent sites for secondary growth resulting from 
metastasized breast cancer include the liver, lungs, bones, and brain2. 
Once the cancer has spread to these distant sites, the 5-year survival rate 
drops to 27%10. Patients diagnosed with metastatic breast cancer within 
the brain tend to receive the worst prognosis in terms of patient life 
outlook, with a median survival ranging from 2 to 25.3 months, along 
with a greatly reduced quality of life11. For the most invasive category of 
breast cancer, triple negative breast cancer, the survival time is at its 
lowest, at 3 to 4 months for patients that have developed a secondary 
growth in the brain11. In comparison, HER2-positive breast cancers, the 
next leading breast cancer type for brain metastasis, show longer reported 
survival rates even with a higher rate of brain metastases11. This project 
will only focus on breast cancer metastasis in the brain. 
A primary goal of this study will be to investigate the biological 
response of breast cancer cells when exposed to environments that 
resemble the breast and brain. By tracking cell behaviors within 
sophisticated extracellular matrix-mimicking models, more information 
concerning invasivity and treatment options can become more evident. 
Within this study, I will be incorporating the use of complex hydrogel 
solutions to encapsulate cells, and I will study their response to these 
breast and brain-mimicking three dimensional (3D) environments. Along 
with these models, I will be positioning cells from the same cancer cell 
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lines on hydrogel solution surfaces to observe their behavioral response 
on a flat two-dimensional (2D) surface compared to that of a fully 3D 
encapsulated behavior. 
 
Hydrogels 
Hydrogels, or ’hydrophilic gels’, are composed of three-dimensional 
networks of polymer chains within an aqueous dispersion medium. What 
separates hydrogels from traditional colloidal gels, which include solid 
particle networks within a liquid solvent, is that hydrogels are capable of 
retaining a large ratio of water in comparison to the crosslinking 
material12. The properties of hydrogels provide distinct advantages of 
increased biocompatibility, tunable biodegradability, and porous 
structures deriving from the nature of the polymer chain networks. 
Hydrogels are considered prime candidates for applications in biosensing, 
drug delivery, and as carriers or matrices for cells in tissue engineering13. 
In a previous study, gelatin methacrylamide (GelMA)-based hydrogels 
were synthesized to support in vitro and in vivo spheroid-based models to 
investigate ovarian cancer in its advanced stages14. 
Hydrogel 3D models are used because the behavior of 3D-cultured 
cells is more reflective of physiological cellular responses in vivo. 
Research has shown that cells studied in 3D environments exhibit 
morphologies and physiologies that better reflect in vivoconditions than 
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those cultured in 2D environments15. Important differences that will be 
critical to this study between 2D and 3D modeling include differentiation, 
gene expression, general cell function, morphology, and proliferation 
changes. The effects of cell morphology in 2D vs. 3D can be seen in 
Figures 1 and 2. 
 
Figure 1: Characteristic behavior of cells grown on a 2D glass surface15 
      
Figure 2: Characteristic behavior of cells grown within 3D collagen gel15 
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Collagen  
Collagen is the main structural protein of the extracellular matrix 
in various connective tissues in the body, including the breast. Collagen 
alone makes up 25% to 35% of the entire body content of mammals16. In 
this investigation, fibrillar type I collagen was used because it is 
considered the most abundant within the body, making up over 90% of 
the collagen within the human body12. Collagen hydrogels have also been 
widely used in 3D scaffolding because they more closely mimic in vivo 
anatomy than traditional cellular monolayers supported on tissue culture 
polystyrene17. For this investigation, collagen will be the primary building 
block for most hydrogel models, and hydrogels with polymer chain 
networks consisting only of collagen will be used to characterize cell 
behavior within the breast environment. 
 
Hyaluronic acid 
 Hyaluronic acid (HA) is an anionic, nonsulfated 
glycosaminoglycan distributed widely throughout connective, epithelial, 
and neural tissues18. Within the brain, HA is in high abundance along 
with lecticans and proteoglycans that contain a lectican and HA binding 
domain. The extracellular matrix within the brain is thought to provide 
resistance to invading cells of a non-neural origin18. For this reason, HA 
is used within this investigation to model the brain extracellular matrix in 
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order to study the cellular response of the breast cancer cells when 
exposed to this environment. It is also worth noting the presence of HA 
within extracellular matrices contributes significantly to cell proliferation 
and migration and may also be involved in the progression of some 
malignant tumors19. In cell migration, HA serves several functions 
ranging from purely structural to developmental regulation via control of 
tissue macro- and microenvironments20. 
HA is an important factor in cell migration because of its innate 
physicochemical properties and its direct interactions with cells. HA 
directly interacts with three principal cell receptors, CD44, RHAMM, and 
ICAM-121. Although RHAMM is the receptor most attributed to cell 
migration21, the cell receptor of most importance within this group is 
CD44, as it is a common marker of breast cancer stem cells22. A previous 
study showed that CD44 is a highly important cell receptor, as CD44 
interactions with HA strongly stimulate migration in all tested glioma cell 
lines, inducing promoting cell detachment and invasion23. 
 
Cell lines 
For this investigation, three cell lines, MDA-MB-231, MCF-7, 
and MCF10a were individually studied in similar experimental models in 
order to find distinct differences in cellular response to hyaluronic acid 
and collagen within 2D and 3D culture environments. Each cell line 
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provides unique characteristics in terms of invasivity and proliferation, 
and these were used to provide more depth to the investigation. 
 
MDA-MB-231 
The MDA-MB-231 cell line is an epithelial, human breast cancer 
cell line that was established from a pleural effusion of a 51 year old, 
Caucasian female with a metastatic mammary adenocarcinoma. MDA-
MB-231 is one of the most studied breast cancer cell lines in medical 
research laboratories. It is highly aggressive and highly invasive. This cell 
line lacks estrogen receptors and progesterone receptors (ER,PR-), while 
amplifying human epidermal growth factor 2 (HER2+) production24. 
Because of these mutations, MDA-MB-231 can be classified as a poorly 
differentiated triple-negative breast cancer, which also matches the 
aggressive nature of the cell line. MDA-MB-231 shows expression of the 
CD44+CD24-/low phenotype, which is similarly found in mammary 
cancer stem cells and characterizes cells with highly invasive properties24. 
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                         Figure 3: MDA-MB-231 cells in culture24 
MCF7 
MCF-7 is a breast cancer cell line isolated from a 69-year old, 
Caucasian woman in 197025. The cell line for MCF-7 was established in 
1973 and was the first mammary cell line capable of living longer than a 
few months. Being the first immortalized mammary cell line, as well as 
the first immortalized breast cancer cell line, to be applied within medical 
laboratories, MCF-7 has been widely investigated and understood through 
years of research26. MCF-7 is characterized as a primary tumor. MCF-7 
does exhibit response to estrogen, and has been shown to be HER2 
negative (HER2-) and to exhibit estrogen and progesterone 
receptors(ER/PR+)25. 
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                            Figure 4: MCF7 cells in culture27 
 
MCF10a 
MCF10a is a human breast epithelial cell line that is likely the 
most applied normal breast cell line within medical laboratories28. The 
cells were derived from benign proliferative breast tissue. They are not 
considered tumorigenic, and their immortalization is mostly associated 
with depletion of the genes p16 and p14ARF, which regulate cellular 
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senescence28. For the purpose of this investigation, MCF10a is used as a 
control group to compare the behavior of the breast cancer cell lines 
MDA-MB-231 and MCF7 with the expected behavior of normal 
mammary cells.  
 
                        Figure 5: MCF10a cells in culture29 
Cell behavior: Migration and morphology 
The primary goal of the study is to investigate the behaviors of 
cell lines MDA-MB-231, MCF7, and MCF10a, within collagen, HA, and 
collagen-HA composite hydrogels. Tumor cells exhibit primarily two 
distinct modes of migration when invading the 3D environment: 
mesenchymal movement and amoeboid movement. These two types of 
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invasive movements are interchangeable due to cellular plasticity: 
suppression or enhancement of the activity of specific molecular 
pathways can cause a switch from one type to another. This change has 
been termed the mesenchymal amoeboid transition (MAT), or 
alternatively the amoeboid mesenchymal transition (AMT)30. MAT and 
AMT can occur quickly based on the specifics of the environment 
surrounding the cell in question. Each movement pattern has its unique 
advantages and disadvantages. 
 
 
 
Figure 6: Visual representation of amoeboid (left) and mesenchymal (right) 
morphologies31 
 
Mesenchymal movement 
 The mesenchymal type of migration is similar to the movement of 
fibroblasts. Cells with this type of motility have a specific, elongated, 
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spindle-like shape. In a 3D space, like the one created within this 
investigation, the cells polarize, showing an obvious leading edge with a 
lagging body30. Actin generates traction forces between the polarized 
edges, and clustered integrins provide focal adhesions that then recruit 
ECM-degrading proteolytical enzymes to remodel the nearby ECM and 
provide a path by which the cell can migrate30. This movement type is 
believed to be somewhat slower because of slow turnover of focal 
adhesions during translocation30. 
 
Amoeboid movement 
 The amoeboid type of migration is named based on its likeness to 
a specific type of motility found in amoebas, characterized by cycles of 
expansion and contraction of the cell body mediated by localized actin 
and myosin30. Tumor cells that adopt an amoeboid-like invasive pattern 
have a characteristic round shape in 3D matrices. The low adhesion 
attachment style found within amoeboid movement allows cells to travel 
through 3D environments at relatively high speeds30, barring physical 
barriers in the matrix. 
 
Expected results 
 The formation and use of 3D in vitro environments has been a 
topic of several studies that examine cancer cell behavior32. Evidence 
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shows that characteristics of tumor cell growth in 3D in vitro 
environments better reflect in vivo tumor cell growth behavior than those 
seen in 2D in vitro environments because 3D environments capture 
unique cell-cell and cell-matrix interactions33. Numerous breast cancer 
cell lines have been found to display different cell morphology and gene 
expression patterns across 2D and 3D environments34. Cancer cell 
invasion rates have been found to correlate with the generation and 
presence of HA within the surrounding extracellular matrix (ECM)35. The 
morphology of cells within 3D environments has also been correlated to 
levels of invasiveness based on morphologic factors36,37. 
Based on this, there are several hypotheses that were formed for 
this experiment. These results will be centralized around each cell line’s 
migrational and morphological response resulting from the presence of 
HA within the hydrogel environment and from the placement of cell in 
2D or 3D environments. 
 
General trends 
 In an overall comparison of the three mammary cell lines, MDA-
MB-231 is expected to migrate at a faster rate than MCF7, as MDA-MB-
231 has been characterized as a more invasive cell line24. MCF10a is 
expected to migrate the least of the three because MCF10a is the control 
group that should resemble normal mammary cell behavior within this 
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study. Similarly, MDA-MB-231 is expected to exhibit more elongated, 
mesenchymal-like movement than MCF7. MDA-MB-231 is considered 
more capable of metastases because of its categorization as a poorly 
differentiated triple negative breast cancer as well as its distinct 
characteristics of invasion, due to their stellate projections that often 
bridge multiple cell colonies in 3D cell culture24. For this reason, MDA-
MB-231 is expected to exhibit more elongated cell shapes that correlate 
with mesenchymal-like migration. Since MCF7 is categorized as less 
invasive than MDA-MB-231, this cell line is not expected to exhibit a 
morphology as elongated as MDA-MB-231. Since MCF10a is not 
expected to show any signs of migration, the morphology of the cells 
should be spheroid in nature and should show no signs indicative of 
elongation28. 
 
Response to HA 
 MDA-MB-231 is expected to have improved migration rates in 
comparison to the other cell lines when in the presence of HA in the 
hydrogels. MDA-MB-231 has a CD44+CD24-/low phenotype, thus 
increased expression of CD44 protein receptors should allow for 
increased adhesion and movement throughout a hydrogel containing HA 
polymers24. MCF7 is expected to not have improved migration rates in 
the presence of HA. Unlike MDA-MB-231, MCF7 does not overexpress 
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CD44 protein receptors, and as such, is less likely to adhere to HA 
polymers and migrate through an HA-containing hydrogel24. For this 
reason, MCF7 is expected to have decreased movement speed resulting 
from the lack of adherence to HA and because of increased movement 
resistance in the presence of the additional polymer chains of HA. 
MCF10a is not expected to show any major response in migration or 
morphology resulting from the presence of HA. Since MCF10a is the cell 
line that is used to mimic normal mammary cell behavior as a control 
within this experiment, no migrational response is expected with or 
without the inclusion of HA24. 
 
Differences between 2D and 3D conditions 
 The general expected trend across all cell lines is that cells will 
decrease migration speed when encapsulated in 3D hydrogel models 
compared to that observed when deposited on hydrogel surfaces in 2D 
models. The reasoning for this is that the increased resistance of polymer 
chains within the 3D model will add extra resistance to movement. It is 
expected that MDA-MB-231 could possibly experience less resistance 
between 2D to 3D models because of this cell line’s ability to elongate 
and adopt a more mesenchymal-like migration behavior24. The reasoning 
for this is that MDA-MB-231 cells will be able to squeeze through spaces 
between polymer chains within the hydrogel more readily because of 
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their ability to elongate. Previous studies have found that MDA-MB-231 
are able to readily squeeze through junctions, adding to their 
characterization as a more aggressive cell line24. Since MCF7 is expected 
to migrate in a more amoeboid-like fashion, it will have a more difficult 
time migrating through a 3D hydrogel likely because of increased 
resistance from the polymer chains. MCF10a will likely not show any 
difference in migration behaviors, as MCF10a migration will likely be 
minimal in both 2D and 3D models.
18 
 
Chapter 2: Methodology 
Cell Cultures 
All cell lines were grown separately in 250 ml culture flasks and 
maintained in an incubator set to 37°C with 5% CO2. All cell culture 
medium was based on methods advised by the cell vendors24,27,29. All cell 
culture media used Dulbecco’s Modified Eagle Medium (DMEM) 
(Invitrogen) as the media base. The MDA-MB-231 growth medium was 
supplemented with 10% volume FBS (Sigma F6178), 1% volume 
Penicillin-Streptomycin (Invitrogen/Gibco 15140-148) and 1 ml Mycozap 
solution. The MCF-7 growth medium was supplemented with 10% 
volume FBS, 1% volume Penicillin-Streptomycin, 1 ml Mycozap 
solution, and 0.01 mg/ml Recombinant Human Insulin (Sigma 91077C-
100MG). The MCF-10a growth medium was supplemented with 5% 
volume Horse Serum, 1% volume Penicillin-Streptomycin, 20 ng/ml 
Epidermal Growth Factor (EGF) (Sigma E9644), 0.5 mg/ml 
Hydrocortisone (Sigma H0888), 50 µg/ml Cholera Toxin (Sigma C8052), 
0.01 mg/ml insulin, and 1 ml MycoZap. Composition of each medium 
was not taken into consideration for during experiment analyses. 
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Cell medium was changed every two days, and cells were passaged 
once cell confluency exceeded 70%. The time intervals between 
passaging varied between cell lines based on their growth rates. 
For passaging, cells were washed with 5 ml phosphate buffered saline 
(PBS) without calcium and magnesium [Sigma P3813], and then exposed 
to 3 ml Trypsin-EDTA [Sigma T4049]. Exposure time of the Trypsin-
EDTA solution varied among cell lines because of differences in the 
levels of adherence. Once the cells were no longer adherent to the cell 
culture flask, 8 ml of medium was added to the cell culture well to dilute 
the Trypsin-EDTA solution, and the contents of the cell culture flask 
were transferred a conical tube and centrifuged for 3 minutes at 3500 
RPM. The liquid waste was removed, and the cell pellet was resuspended 
within the conical tube using cell culture medium. 10% of the cells in 
suspension were deposited into a new 250 ml cell culture flask along with 
15 ml of cell culture medium. 
 
Model Preparation 
For model preparation, the work required was divided into three 
distinct parts: cell staining, hydrogel preparation, and hydrogel well 
preparation. Several of the tasks were done in tandem with others, and a 
general schedule for the model preparation process can be seen in     
Table 1. 
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Table 1: General 
timetable for each 
conducted 
experiment 
 
Cell staining 
Cell preparation for experimentation occurred as part of the 
routine cell passaging procedure. Once the cell pellet was isolated from 
the liquid waste, the cells were suspended in a conical tube with 1 ml of 
DMEM solution. 10 l of cell solution was isolated and diluted by a 
factor of 10 with 90 l of DMEM. 10 l of the diluted cell solution was 
then used for cell counting. Based on the calculated cell concentration in 
the 1 ml of cell-suspended DMEM, the necessary volume of cell 
suspended DMEM was isolated and diluted in DMEM to obtain a 1 ml 
Task Time to start Time required Time at completion 
Thaw HA 0:00 20 min 0:20 
Dissolve HA 0:20 20 min 0:40 
Count cells 0:10 30 min 0:40 
Thaw Extralink 0:35 5 min 0:40 
Stain cells HA 0:40 60 min 1:40 
Prepare base gels 0:40 20 min 1:00 
Base gel solidification 1:00 40 min 1:40 
Prepare body gels 1:40 30 min 2:10 
Body gel 
solidification 
2:10 50 min 3:00 
Add media 3:00 5 min 3:05 
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solution of 500,000 cells/ml in a microcentrifugal tube. To the 500,000 
cells/ml solution, 0.5-1 l of CellTracker Green CMFDA Dye 
[ThermoFisher C7025] was added, based on the freshness of the dye. The 
500,000 cells/ml solution while in the microcentrifugal tube was then 
placed in a 37°C and 5% CO2 incubator to allow the dye to adhere to the 
cells. 
 
Hydrogel preparation 
Hydrogel solution was one of the two primary variables within 
this study. Typically, 20% of the hydrogel solution was composed of the 
stained 500,000 cells/ml solution, 20% collagen solution (unless the 
hydrogel were to consist of only HA), and variable amounts of DMEM 
and HA solution. Solid HA was suspended in 1 ml DMEM and allowed 
to dissolve before addition to hydrogel solutions. Extralink was added 
along with the HA solution to allow the HA to crosslink and form 
polymer chains within the collagen hydrogel. HA and extralink were 
added in a 4:1 ratio. Tables 2 and 3 display all hydrogel composition 
parameters used within these experiments. 
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Components 
Pure 
Collagen 
Coll 
w/0.1wt% 
HA 
Coll 
w/0.2wt% 
HA 
0.1wt% 
HA 
0.2wt% 
HA 
Collagen 20% 20% 20% 0% 0% 
DMEM 80% 67.5% 55% 87.5% 75% 
HA 0% 10% 20% 10% 20% 
Extralink 0% 2.5% 5% 2.5% 5% 
Table 2: Hydrogel components by percent makeup for the hydrogel base layer 
 
Components 
Pure 
Collagen 
Coll 
w/0.1wt% 
HA 
Coll 
w/0.2wt% 
HA 
0.1wt% 
HA 
0.2wt% 
HA 
Collagen 20% 20% 20% 0% 0% 
DMEM 60% 47.5% 35% 67.5% 55% 
Cell Solt. 20% 20% 20% 20% 20% 
HA 0% 10% 20% 10% 20% 
Extralink 0% 2.5% 5% 2.5% 5% 
Table 3: Hydrogel components by percent makeup for the 3D encapsulation layer 
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Hydrogel well preparation 
Hydrogels were prepared in 48 well cell culture plates. For both 
cell encapsulation and cell surface experiments, a hydrogel base layer of 
150 l was formed. The hydrogel base layer was incubated at 37°C for 
roughly one hour, depending on hydrogel composition, to allow hydrogel 
components to crosslink and gelate. Once the hydrogel was formed, for 
cell surface experiments, 1 ml of growth medium and 12,500 cells (25 l 
of a 500,000 cell/ml solution) were added to the well. For encapsulation 
experiments, 100 l of hydrogel solution containing 100,000 cells/ml was 
added to the well. Cell-encapsulated hydrogels were allowed to crosslink 
and gelate for approximately 50 minutes at 37°C. After gelation, 1 ml of 
growth medium was added to each well. For every experimental run, six 
conditions were analyzed. 
 
Microscopy 
Cells in hydrogels were kept overnight in an incubator set to 37°C 
and 5% CO2. The wells were then fixed within a microscopy device for 
imaging. Images of cells were taken at 20x and were used for morphology 
studies. Time-lapse recordings were taken at 10x magnification and 
images were taken every 20 minutes for 8 hours. 
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Analysis methods 
All cell images were analyzed using the software NIH ImageJ 
(NIH). Morphology was analyzed via aspect ratio analysis. Migration 
studies were analyzed using the third party extension MTrackJ. Pixels 
travelled by individual cells over the time lapse was converted to m/hr. 
Statistical analysis of all data was performed using the software JMP, and 
non-parametric Wilcoxon multiple comparison tests were used to identify 
data significance.
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Chapter 3: Results and Discussion 
One of the primary goals of this investigation was to evaluate the 
validity of the collagen/HA hydrogel composite model for the study of 
breast cancer cells. Here, the results of the migration and morphology 
analyses will be presented as well as a discussion on the meaning behind 
each set of results. 
 
Hydrogel composition effects on migration 
From the conducted investigation, an overall difference in 
migration speeds across all experimental cell lines was observed (Figures 
7-8). MDA-MB-231 cells across all conditions moved at speeds of 50 to 
90 microns/hour, MCF7 cells moved at 30-60 microns/hour, and MCF10a 
cells showed no apparent signs of movement. Upon further analysis of the 
MDA-MB-231 migration data, few significant differences in average 
migration were found across hydrogel composition trials containing 
collagen (Figure 7). A significant change in cell behavior was only 
detected for the 2D 0.1wt% HA-Collagen hydrogel condition. Within 
hydrogels consisting of HA only and no collagen, migration values began 
to diverge. For the two conditions tested with absolute HA hydrogels (no 
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collagen), the cells deposited on the hydrogel surface moved much faster 
than cells encapsulated within the same hydrogel. Although the two 
encapsulated conditions were found to be statistically similar, cells 
deposited on surfaces of hydrogels composed of 0.1wt% HA were found 
to move significantly faster than those on hydrogels of 0.2wt% HA. 
MCF-7 cells exhibited a different response to the addition of HA 
within the hydrogel experiments that that of MDA-MB-231 cells (Figure 
8). MCF-7 cells exhibited reduced migration speed in response to 
increased HA. In experiments with hydrogels consisting solely of HA, 
MCF-7 displayed a large increase in migration speeds for three of the 
four conditions (2D and 3D 0.1wt% HA and 2D 0.2wt% HA) compared 
to cells cultured in collagen containing hydrogels.  
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Figure 7: Migration data from MDA-MB-231/hydrogel experiments. Letters indicate 
statistical similarity between experimental groups (N>90 per data point, p=1.00). 
Insufficient data for data set 0.2 3D HA ABS due to lab shutdown. 
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Figure 8: Migration data from MCF-7/hydrogel experiments. Letters 
indicate statistical similarity between experimental groups (N>130 per 
data point, p=1.00) 
 
Discussion on migration 
Overall migration differences 
The overall migration rates for each cell line within this study match 
expected rates based on recorded characterization of the cell lines24,28,39. 
MDA-MB-231 was the fastest moving cell line across all conditions 
within collagen or collagen/HA composite hydrogels. MDA-MB-231 is 
one of the most aggressive, invasive, and well researched breast cancer 
cell lines studied today24. MCF7, which also has been greatly studied over 
the past 40 years, is less aggressive and is primarily used in primary 
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tumor growth models39. In previous studies, MCF7 has been shown to 
increase in invasiveness and metastatic tendencies with the addition of 
estrogen39. Since estrogen was not applied in this study, MCF7 was thus 
expected to behave in a less aggressive manner. Therefore, the 
experimental results showing MCF7 displaying lower migration rates to 
that of MDA-MB-231 is consistent with its behavior in other studies as a 
less invasive cell line. 
MCF10a showed little to no signs of movement to such a degree that 
viable, quantitative migration data could not be collected from MCF10a 
experiments. This behavior matches the previously recorded behaviors of 
MCF10a under similar conditions28. Images of MCF10a cells, along with 
the other cell lines, would normally be included to show qualitative 
differences between lines; however, because of the stay-at-home order 
during the 2020 COVID-19 quarantine, the pictures of these cells were 
inaccessible from the laboratory. 
MDA-MB-231 migrational response 
These findings from this study suggest that MDA-MB-231 is not 
hindered by the introduction of HA to a collagen-based hydrogel. These 
results are in line with the previous understanding of the interaction of 
CD44 and HA. MDA-MB-231 is a poorly differentiated triple negative 
breast cancer cell line with a CD44+/CD24- low phenotype24. The CD44 
protein binds to HA and has roles in cell detachment, stimulating 
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migration, and promoting invasion23. Based on this information, because 
of CD44 receptor activity in MDA-MB-231 cells, the presence of HA 
should stimulate cell migration. The significant increase in cell migration 
for the 2D 0.1wt%HA group in collagen supports this notion, as the 
presence of HA induced faster cell movement. For the, 3D 0.1wt%HA in 
collagen,  the lack of significant change likely results from the increased 
stiffness of the hydrogel because of the increased concentration of 
polymer chains. This increased stiffness could result in an increased 
amount of resistance within the cell migration path, slowing the cells. For 
the 2D 0.2wt% HA in collagen, the lack of significant change could be 
due to the increased amount of matrix degradation required due to the 
doubled amount of HA within the hydrogels42. 
 
MCF7 migrational response 
Within the collagen and collagen/HA composite hydrogel conditions, 
MCF7 migration declined significantly with the introduction of HA to 
collagen-based hydrogel solutions. A previous study showed that MCF7 has 
low expression of CD44, the cell receptor responsible for cancer cell 
interaction with HA40. A decline in mobility for a CD44-lacking cell line in 
response to HA exposure compared to a rise in mobility for a CD44-
abundant cell supports the theory that CD44 expression positively impacts 
cell mobility in an environment containing HA. 
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For hydrogels consisting of only HA and no collagen, the movement of 
the MCF7 cells was faster and significantly similar across three of the 
conditions. Because of the overall inability of the MCF7 cells to adhere to 
HA polymers, this increased rate of migration is likely a result of the MCF7 
cells floating within the hydrogel because of a lack of adhesion to the HA 
infrastructure and because of the movement of the microscope tray during 
the time-lapse imaging. Without the ability to adhere to their surroundings, 
cells likely moved involuntarily during the migration study because of the 
fluid motion in response to the tray movement. This inference is supported 
by a few recordings that show cells floating towards the meniscus of the 
hydrogel; however, these recordings were unobtainable for review because 
of the stay-at-home order during the COVID-19 quarantine. 
 
Validity of the hydrogel models 
The evidence from both MDA-MB-231 and MCF7 experiments 
support the claim that collagen and collagen/HA composite hydrogel 
models can reliably be used to investigate cellular migration and invasion 
responses to the presence of HA. The experimental behavior of MDA-
MB-231 and MCF7 cell lines matched the hypothesized behavior of the 
two cell lines; MDA-MB-231 is characterized a highly aggressive cell 
line24 while MCF7 is not25. , and the data showed that increased 
expression of CD44 correlated with increased ability of cells to navigate 
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polymer matrices containing HA. These models should be viable for 
further study of cells expressing CD44. 
Although HA hydrogel conditions did prove to be beneficial to this 
study, the protocol for the synthesis of the HA hydrogels will likely need 
to be reviewed. In this investigation, the HA concentration as well as the 
time made available for polymer chain crosslinking within the hydrogel, 
likely were not suitable for forming hydrogels with adequate structural 
integrity. For this reason, future experiments increasing the HA 
concentration could prove to be fruitful. 
 
Validity of the MCF10a cell line 
The study of MCF10a within this investigation was explored to 
compare two breast cancer cell lines, MDA-MB-231 and MCF7, to a 
normal mammary cell. Although MCF10a did behave in an expected 
fashion within this study, a previous study has shown that MCF10a cells 
in 3D culture exhibit unique cellular expressions that do not match that of 
normal mammary cells in vivo 41. For this reason, MCF10a was useful as 
a control group, but further use of MCF10a may not be as viable as 
initially expected. 
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Hydrogel composition effects on morphology 
Aspect ratio was the determinant used to classify cells as either 
mesenchymal or amoeboid in morphology. Neither MDA-MB-231 nor 
MCF-7 cells showed a significant pattern in morphology (Figure 9). There 
was no indicative change in morphology patterns for MDA-MB-231 cells 
based on the addition of HA to a collagen hydrogel base. There was, 
however, a decrease in aspect ratio when MDA-MB-231 was exposed to 
HA-only hydrogel environments. For MCF-7, the aspect ratio declined 
significantly when the cells were exposed to environments where HA made 
up a large proportion of the hydrogel matrices (Figure 10).  
 
Figure 9: Average aspect ratio values of MDA-MB-231 hydrogel experiments. Letters 
indicate statistical similarity between experimental groups (N>80 per data point, 
p=0.7911). 
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Figure 10: Average aspect ratio values of MCF7 hydrogel experiments. Stars indicate 
statistical difference between experimental groups (N>100 per data point, p=0.6436). 
Insufficient data for data sets 0.2 2D HA ABS and 0.2 3D HA ABS due to lab shutdown. 
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Discussion on morphology 
Overall morphology response 
MDA-MB-231 and MCF-7 cell lines exhibited different ranges of cell 
morphology. MDA-MB-231 in almost all morphology analyses displayed 
an average aspect ratio in collagen and collagen/HA composite hydrogels 
of  > 1.3. Comparatively, MCF7 did not display an average aspect ratio of 
> 1.26 over any condition. This difference can likely be explained by the 
inherent differences of the cells: MDA-MB-231 cells are more fibrillar in 
appearance and were expected to exhibit a more elongated shape with a 
high AR24, whereas MCF7 cells are more rounded and thus exhibit 
morphologies with a lower AR27. 
 
MDA-MB-231 morphology response 
The results from the MDA-MB-23 morphology analysis reveal that 
overall morphological behavior of the cell line is independent of the 
concentration of HA in hydrogel conditions, including collagen. The only 
significant change in cell morphology occurred in the 3D 0.1wt%HA and 
3D 0.2wt%HA hydrogels. This is likely because of a lack of polymer 
adherence available in comparison to the hydrogels containing collagen; 
within the pure HA conditions, there was at least a 50% drop in polymer 
chains within the hydrogel compared to the pure collagen conditions 
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MCF7 morphology response 
For MCF7, a significant decrease in aspect ratio was seen in both the 
2D and 3D 0.2wt%HA/collagen composite hydrogel conditions. This can 
likely be attributed to reduced adhesion locations because of the included 
HA polymers; MCF7 struggles to bind to HA because of low expression 
of CD4440.
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Conclusions 
In this study, I examined the variation in cell migration and 
morphology of the breast cell lines MCF10a, MDA-MB-231, and MCF-7 
when encapsulated within hydrogels or deposited on top of a hydrogel 
base. The hydrogels used in experiments were made from a range of 
compositions of collagen and/or HA. HA and collagen were chosen as the 
hydrogel components in order to mimic a breast extracellular 
environment (i.e., which is composed primarily of collagen), and a brain 
extracellular environment (i.e., which is composed primarily of HA). The 
purpose of performing experiments with these hydrogels was to 
investigate the viability of the hydrogel model, while also furthering 
understanding of cancer cell migration behaviors. The results of this 
study showed that highly invasive MDA-MB-231 cells were not hindered 
by the addition of HA, whereas less invasive MCF-7 cells slowed 
migration rates in response to the introduction of HA to collagen 
hydrogels. As a control, MCF10a was also investigated for its 
morphology and migration patterns in these hydrogels; however, these 
cells showed no signs of movement for any condition. Based on the 
results of this study and the literature reported characteristics of each cell 
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line, these hydrogel models were shown to be promising for studying cell 
migration behaviors. These hydrogel models can be expanded to 
investigate cells in environments mimicking other body sites, not just the 
breast and the brain, through the use of collagen and HA. With an 
increase in complexity in hydrogels, more intricate models could be 
considered, suitable for studying cell invasion through a cell barrier or a 
thick hydrogel barrier. 
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